Point72 Asset Management
TBPH icon

Point72 Asset Management’s Theravance Biopharma TBPH Stock Holding History

Point72 Asset Management’s Portfolio TBPH Stock Details TBPH Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
2025
Q2 		$140K Buy
2022
Q3 		– Sell
2022
Q2 		$959K Sell
2022
Q1 		$6.27M Buy
2021
Q4 		$1.6M Sell
2021
Q3 		$25.2M Buy
2017
Q2 		– Sell
2017
Q1 		$3.34M Sell
2016
Q4 		$5.44M Buy